Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent CDI”

50 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 50 results

Post-approval studies (Phase 4)WithdrawnNCT05077085
What this trial is testing

Bezlotoxumab Versus FMT for Multiple Recurrent CDI

Who this might be right for
Clostridium InfectionsClostridioides DifficileEnterocolitis, Pseudomembranous
Leiden University Medical Center
Not applicableLooking for participantsNCT07250724
What this trial is testing

C. Difficile Toxin Levels in Stool From Healthy Individuals Following Standard of Care Antibiotic Treatment for CDI.

Who this might be right for
Clostridioides Difficile Infection Recurrence
Bactolife A/S 60
Testing effectiveness (Phase 2)Study completedNCT02299570
What this trial is testing

Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection

Who this might be right for
Enterocolitis Clostridium Difficile Recurrent
Rebiotix Inc. 150
Testing effectiveness (Phase 2)Study completedNCT01398969
What this trial is testing

Multi-Centre Trial of Fresh vs. Frozen-and-Thawed FMT for Recurrent CDI

Who this might be right for
Clostridium Difficile Infection
McMaster University 232
Testing effectiveness (Phase 2)Ended earlyNCT02255305
What this trial is testing

FMT Versus Antimicrobials for Initial Treatment of Recurrent CDI

Who this might be right for
Clostridium Difficile Infection
Endeavor Health 6
Post-approval studies (Phase 4)Ended earlyNCT04000555
What this trial is testing

Oral Vancomycin for Secondary Prophylaxis of Clostridium Difficile Infection (CDI)

Who this might be right for
Clostridium Difficile InfectionClostridium Difficile Infection Recurrence
University of South Florida 26
Large-scale testing (Phase 3)Ended earlyNCT01226992
What this trial is testing

Oral Vancomycin Followed by Fecal Transplant Versus Tapering Oral Vancomycin

Who this might be right for
Recurrent Clostridium Difficile InfectionLaboratory Confirmed Clostridium Difficile Infection
University Health Network, Toronto 81
Large-scale testing (Phase 3)Looking for participantsNCT06979609
What this trial is testing

Secondary Prevention of Clostridioides Difficile Using Vancomycin

Who this might be right for
Clostridioides Difficile InfectionClostridioides Difficile Infection RecurrenceClostridoides Difficile Associated Disease
McGill University Health Centre/Research Institute of the McGill University Health Centre 300
Large-scale testing (Phase 3)Study completedNCT05831189
What this trial is testing

A Multi-center, Single-arm Trial Exploring the Safety and Clinical Effectiveness of RBX2660 Administered by Colonoscopy to Adults With Recurrent Clostridioides Difficile Infection

Who this might be right for
Clostridium Difficile Infection Recurrence
Ferring Pharmaceuticals 41
Not applicableUnknownNCT04012788
What this trial is testing

CDI Synbiotic Study

Who this might be right for
Clostridium Difficile Infection
Hvidovre University Hospital 50
Post-approval studies (Phase 4)Study completedNCT03880539
What this trial is testing

Bezlotoxumab (BEZLO) In Addition To Standard Of Care (SOC) Vancomycin For The Treatment of Multi-Recurrent Clostridium Difficile Infection

Who this might be right for
Clostridium Difficile Infection Recurrence
University of Kansas Medical Center 4
Testing effectiveness (Phase 2)Study completedNCT03806803
What this trial is testing

Multicentre Blinded Comparison of Lyophilized Sterile Fecal Filtrate to Lyophilized Fecal Microbiota Transplant in Recurrent Clostridioides Difficile Infection

Who this might be right for
Clostridia Difficile ColitisClostridium Difficile Diarrhea
University of Alberta 138
Testing effectiveness (Phase 2)Study completedNCT03497806
What this trial is testing

Open-Label Extension of CP101 Trials Evaluating Oral Full-Spectrum Microbiota™ (CP101) in Subjects With Recurrence of Clostridium Difficile Infection

Who this might be right for
Clostridium Difficile InfectionRecurrent Clostridium Difficile InfectionC. Diff+8 more
Finch Research and Development LLC. 132
Testing effectiveness (Phase 2)Study completedNCT03110133
What this trial is testing

Efficacy, Safety, and Tolerability Study of Oral Full-Spectrum MicrobiotaTM (CP101) in Subjects With Recurrent C. Diff

Who this might be right for
Clostridium Difficile Infection Recurrence
Finch Research and Development LLC. 206
Testing effectiveness (Phase 2)Study completedNCT03788434
What this trial is testing

Phase 2 Study of VE303 for Prevention of Recurrent Clostridioides Difficile Infection

Who this might be right for
Clostridium Difficile Infection RecurrenceClostridium Difficile InfectionClostridium Difficile+4 more
Vedanta Biosciences, Inc. 79
Testing effectiveness (Phase 2)Ended earlyNCT03617172
What this trial is testing

PROCLAIM -- Misoprostol in the Prevention of Recurrent CDI Prevent Recurrence of Clostridium Difficile Infection With Misoprostol

Who this might be right for
Clostridium Difficile
Vanderbilt University Medical Center 6
Testing effectiveness (Phase 2)Study completedNCT01925417
What this trial is testing

Microbiota Restoration Therapy for Recurrent Clostridium Difficile-associated Diarrhea

Who this might be right for
Recurrent Clostridium Difficile Infection
Rebiotix Inc. 34
Large-scale testing (Phase 3)Study completedNCT02254811
What this trial is testing

FMT Delivered by Capsule Versus Colonoscopy for Recurrent C. Diff

Who this might be right for
Enterocolitis Clostridium Difficile Recurrent
University of Alberta 116
Large-scale testing (Phase 3)Study completedNCT01513239
What this trial is testing

MK-6072 and MK-3415A in Participants Receiving Antibiotic Therapy for Clostridium Difficile Infection (MK-3415A-002)

Who this might be right for
Clostridium Difficile Infection
Merck Sharp & Dohme LLC 1,203
Testing effectiveness (Phase 2)Ended earlyNCT06536465
What this trial is testing

The Clostridioides Difficile Trial of REC-3964

Who this might be right for
Recurrent Clostridioides Difficile Infection
Recursion Pharmaceuticals Inc. 3
Load More Results